PUBLISHER: The Business Research Company | PRODUCT CODE: 1945401
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945401
Interventional radiology, a specialized field within radiology, employs medical imaging techniques to guide minimally invasive surgical procedures for both diagnostic and therapeutic purposes.
The primary products in the interventional radiology market encompass MRI, ultrasound imaging, CT scanners, angiography systems, fluoroscopy systems, biopsy devices, and various others. MRI interventional radiology devices excel in producing detailed images of organs and tissues within the body. The range of procedures performed includes angioplasty, angiography, biopsy and drainage, embolization, thrombolysis, vertebroplasty, nephrostomy, and more. These procedures find application across diverse medical specialties such as cardiology, urology and nephrology, oncology, gastroenterology, and various others.
Tariffs are impacting the interventional radiology market by increasing costs of imported imaging systems, catheters, contrast agents, and interventional accessories used in angiography, fluoroscopy, and biopsy procedures. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on advanced imported imaging equipment, while Asia-Pacific faces cost pressures on system procurement. These tariffs are raising capital expenditure and delaying technology upgrades. However, they are also encouraging localized manufacturing, regional supplier partnerships, and domestic innovation in imaging and interventional device production.
The interventional radiology market research report is one of a series of new reports from The Business Research Company that provides interventional radiology market statistics, including interventional radiology industry global market size, regional shares, competitors with a interventional radiology market share, detailed interventional radiology market segments, market trends and opportunities, and any further data you may need to thrive in the interventional radiology industry. This interventional radiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The interventional radiology market size has grown rapidly in recent years. It will grow from $29.98 billion in 2025 to $33.94 billion in 2026 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to rising prevalence of chronic vascular diseases, increasing adoption of minimally invasive treatment approaches, expansion of hospital imaging infrastructure, growing use of catheter-based interventions, improvements in diagnostic imaging technologies.
The interventional radiology market size is expected to see rapid growth in the next few years. It will grow to $54.31 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing demand for precision oncology interventions, rising investments in advanced imaging systems, expansion of interventional radiology training programs, growing use of image-guided therapies, increasing preference for outpatient interventional procedures. Major trends in the forecast period include increasing adoption of image-guided minimally invasive procedures, rising integration of advanced imaging modalities, growing demand for precision-based interventional therapies, expansion of hybrid operating room installations, enhanced focus on procedure accuracy and patient outcomes.
The rising prevalence of cancer is anticipated to propel the growth of the interventional radiology market in the upcoming years. Cancer is a significant global health issue and ranks as the second leading cause of death in the United States. Interventional radiology employs various techniques, including ablation, embolization, and irreversible electroporation (IRE), to treat cancer and cardiovascular conditions. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that the number of diagnosed cancer cases in the country rose from 160,570 in 2022 to 164,694 in 2023, indicating a substantial increase over the year. This trend underscores the growing incidence of cancer in Australia. Therefore, the increasing prevalence of cancer is driving the growth of the interventional radiology market.
Major companies operating in the interventional radiology market are introducing advanced technological solutions such as the AI-powered Viz Radiology Suite to enhance profitability and competitive positioning. The AI-powered Viz Radiology Suite is an advanced radiology workflow platform developed by Viz.ai that applies artificial intelligence to analyze medical images and support clinical decision-making. For example, in October 2023, GE HealthCare, a U.S.-based medical technology company, obtained FDA 510(k) clearance for its Allia IGS Pulse system. This next-generation image-guided interventional platform features an AI-enabled AutoRight PLUS image chain that automatically adjusts seven imaging parameters in real time. The technology enhances image quality, improves visualization, and helps manage radiation dose during interventional radiology procedures, supporting faster and more efficient clinical decision-making.
In January 2023, GE Healthcare Technologies Inc., a US-based medical technology company, acquired IMACTIS for an undisclosed amount. Motivated by the opportunity to expand its interventional radiology business, integrate complementary technologies, and enhance image-guided therapeutic solutions, the acquisition of IMACTIS, a France-based medical technology company, aligns with GE Healthcare's commitment to advancing its capabilities for the benefit of clients and patients.
Major companies operating in the interventional radiology market are Carestream Health Inc., Siemens Aktiengesellschaft, Koninklijke Philips N.V., General Electric Company, Hitachi Ltd., Canon Medical Systems Corporation, Shimadzu Corporation, FUJIFILM Holdings Corporation, Hologic Inc., Agfa-Gevaert N.V., Esaote S.p.A., Samsung Medison Co. Ltd., Cook Group Incorporated, Medtronic plc, Abbott Laboratories, AngioDynamics Inc., B. Braun Melsungen AG, C. R. Bard Inc., Terumo Corporation, Merit Medical Systems Inc., Penumbra Inc., BTG International Ltd., Guerbet Group, Medrad Inc., MicroPort Scientific Corporation, Neusoft Medical Systems Co. Ltd.
North America was the largest region in the interventional radiology global market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional radiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the interventional radiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The interventional radiology market consists of sales of atherectomy systems, cancer therapies, and balloon catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Interventional Radiology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses interventional radiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for interventional radiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interventional radiology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.